Dr William Edward Houck, MD | |
224 S Woods Mill Rd, Suite 750, Chesterfield, MO 63017-3451 | |
(314) 576-9797 | |
(314) 469-7517 |
Full Name | Dr William Edward Houck |
---|---|
Gender | Male |
Speciality | Obstetrics & Gynecology |
Location | 224 S Woods Mill Rd, Chesterfield, Missouri |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265520282 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | R1C62 (Missouri) | Primary |
Entity Name | Obstetrical Associates Of St Lukes Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1447814181 PECOS PAC ID: 4688908890 Enrollment ID: O20190621001756 |
News Archive
Scientists at The Scripps Research Institute have found clinical evidence that the drug gabapentin, currently on the market to treat neuropathic pain and epilepsy, helps people to quit smoking marijuana.
The hungrier parents are at mealtimes, a new study shows, the more they may feed their young children, which could have implications for childhood obesity.
In a finding with the potential to fundamentally change strategies to slow the global HIV epidemic, a new study called iPrEx shows that individuals at high risk for HIV infection who took a single daily tablet containing two widely used HIV medications, emtricitabine and tenofovir (FTC/TDF), experienced an average of 43.8% fewer HIV infections than those who received a placebo pill. New England Journal of Medicine, is the first evidence that this new HIV prevention method, called pre-exposure prophylaxis or PrEP, reduces HIV infection risk in people.
The safety debate about drug-eluting stents (DES) is still ongoing. In these times of uncertainty about DES safety, the study has shown that DES markedly improve long-term survival compared to modern bare-metal stents (BMS) implantation in patients with acute ST-segment elevation myocardial infarction (STEMI). In our four year investigation, DES demonstrated a significant reduction of mortality in this sick patient subset.
Trillium Therapeutics Inc., a privately-held biopharmaceutical company, announced today that it has raised $1 million from a new undisclosed investor. The funds will be used to advance its lead program, TTI-1612, into clinical trials for the treatment of interstitial cystitis, also known as bladder pain syndrome. The first trial is projected to start in the second half of this year.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr William Edward Houck, MD 224 S Woods Mill Rd, Suite 750, Chesterfield, MO 63017-3451 Ph: (314) 576-9797 | Dr William Edward Houck, MD 224 S Woods Mill Rd, Suite 750, Chesterfield, MO 63017-3451 Ph: (314) 576-9797 |
News Archive
Scientists at The Scripps Research Institute have found clinical evidence that the drug gabapentin, currently on the market to treat neuropathic pain and epilepsy, helps people to quit smoking marijuana.
The hungrier parents are at mealtimes, a new study shows, the more they may feed their young children, which could have implications for childhood obesity.
In a finding with the potential to fundamentally change strategies to slow the global HIV epidemic, a new study called iPrEx shows that individuals at high risk for HIV infection who took a single daily tablet containing two widely used HIV medications, emtricitabine and tenofovir (FTC/TDF), experienced an average of 43.8% fewer HIV infections than those who received a placebo pill. New England Journal of Medicine, is the first evidence that this new HIV prevention method, called pre-exposure prophylaxis or PrEP, reduces HIV infection risk in people.
The safety debate about drug-eluting stents (DES) is still ongoing. In these times of uncertainty about DES safety, the study has shown that DES markedly improve long-term survival compared to modern bare-metal stents (BMS) implantation in patients with acute ST-segment elevation myocardial infarction (STEMI). In our four year investigation, DES demonstrated a significant reduction of mortality in this sick patient subset.
Trillium Therapeutics Inc., a privately-held biopharmaceutical company, announced today that it has raised $1 million from a new undisclosed investor. The funds will be used to advance its lead program, TTI-1612, into clinical trials for the treatment of interstitial cystitis, also known as bladder pain syndrome. The first trial is projected to start in the second half of this year.
› Verified 8 days ago
Dr. Caroline Anne Morgan, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 226 S Woods Mill Rd, Suite 68 West, Chesterfield, MO 63017 Phone: 314-576-0930 Fax: 314-514-8229 | |
Dr. Stephen C Yim, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 226 S Woods Mill Rd, Suite 55 West, Chesterfield, MO 63017 Phone: 314-469-4440 Fax: 314-576-2346 | |
Dr. Laura Irene Moore, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 224 South Woods Mill Road, Suite 750, Chesterfield, MO 63017 Phone: 314-576-9797 Fax: 314-469-7517 | |
Dr. Joe Edward Belew, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 224 S Woods Mill Rd, Suite 750, Chesterfield, MO 63017 Phone: 314-576-9797 Fax: 314-469-7517 | |
Dr. Jessica Baldetti, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 226 S Woods Mill Rd Ste 68w, Chesterfield, MO 63017 Phone: 314-205-6788 Fax: 314-590-5954 | |
Katherine A Maxson, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 226 S Woods Mill Rd, S5w, Chesterfield, MO 63017 Phone: 314-469-0001 | |
Marta I Pineda, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 226 S Woods Mill Rd, Ste 61w, Chesterfield, MO 63017 Phone: 314-205-6957 |